Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis

Hepato-Gastroenterology

Volumn 57, Issue 98, 2010, Pages 326-329

  Wang, Shu Bing ^a   Wang, Jin Hui ^a   Zheng, Ru Hua ^a   Zhong, Bi Hui ^a   Chen, Min Hu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Autoimmune; Glycyrrhizin; Hepatitis; Jaundice; Ursodeoxycholic acid

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLYCYRRHIZIC ACID; URSODEOXYCHOLIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTASIS; CHRONIC LIVER DISEASE; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; HYPERBILIRUBINEMIA; HYPERGAMMAGLOBULINEMIA; LABORATORY TEST; LIVER BIOPSY; LIVER FUNCTION TEST; OBSTRUCTIVE JAUNDICE; PLASMA CELL; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANTI-INFLAMMATORY AGENTS; BIOPSY, NEEDLE; CHOLAGOGUES AND CHOLERETICS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCYRRHIZIC ACID; HEPATITIS, AUTOIMMUNE; HUMANS; JAUNDICE, OBSTRUCTIVE; LIVER FUNCTION TESTS; MIDDLE AGED; URSODEOXYCHOLIC ACID;

EID: 77954109156     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alvarez F, Berg PA, Blanchi FB, Blanchi L, Burroughs AK, Canado EL, et al: International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.
2. Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002 ;36:479-497.
3. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al: Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48:169-176. (Pubitemid 351975541)
4. Sohda T, Shiga H, Nakane H, Nishizawa S, Yoshikane M, Anan A, et al: Rapid-onset primary biliary cirrhosis resembling drug-induced liver injury. Intern Med 2005; 44:1051-1054.
5. Krawitt EL: Autoimmune hepatitis. N Engl J Med 2006; 354:54-66.
6. Bogdanos DP, Invernizzi P, Mackay IR, Vergani D: Autoimmune liver serology: current diagnostic and clinical challenges. World J Gastroenterol 2008; 14:3374-3387.
7. Tang CP, Shiau YT, Huang YH, Tsay SH, Huo TI, Wu JC, et al: Cholestatic jaundice as the predominant presentation in a patient with autoimmune hepatitis. J Chin Med Assoc 2008; 71:45-48.
8. Czaja AJ: Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 1984; 4:1-12.
9. Huang HC, Huang YS, Wu JC, Tsay SH, Huo TI, Wang YJ, et al: Characteristics of autoimmune hepatitis in Taiwan: the 11 years' experiences of a medical center. Zhonghua Yi Xue Za Zhi (Taipei) 2002; 65:563-569.
10. O'Brien C, Joshi S, Feld JJ, Guindi M, Dienes HP, Heathcote EJ: Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis. Hepatology 2008; 48:550-556.
11. Czaja AJ: Behavior and significance of auto antibodies in type 1 autoimmune hepatitis. J Hepatol 1999; 30:394-401.
12. Kuma GI, Yano S, Otomo M: Study on the corticoid-like action of glycyrrhizin and the mechanism of its action. Endocr J 1957; 4:17-27.
13. Heathcote EJ: Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000; 31:1005-1013.
14. LaRusso NF, Schneider BL, Black D, Gores GJ, James SP, Doo E, et al: Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006; 44:746-764.
15. Czaja AJ, Carpenter HA, Lindor KD: Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. Hepatology 1999; 30:1381-1386.